NDC 45629-089

FOTIVDA

Tivozanib

FOTIVDA is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Aveo Pharmaceuticals, Inc.. The primary component is Tivozanib Hydrochloride.

• Product ID: 45629-089_22d362c3-0746-49c4-8109-6f30bfc86cb8
• NDC: 45629-089
• Product Type: Human Prescription Drug
• Proprietary Name: FOTIVDA
• Generic Name: Tivozanib
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 2021-03-10
• Marketing Category: NDA /
• Application Number: NDA212904
• Labeler Name: AVEO Pharmaceuticals, Inc.
• Substance Name: TIVOZANIB HYDROCHLORIDE
• Active Ingredient Strength: 1 mg/1
• Pharm Classes: Kinase Inhibitor [EPC], Tyrosine Kinase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 45629-089-01

24 BOTTLE, PLASTIC in 1 CARTON (45629-089-01) > 21 CAPSULE in 1 BOTTLE, PLASTIC

• Marketing Start Date: 2021-03-10
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "FOTIVDA" or generic name "Tivozanib"

NDC	Brand Name	Generic Name
45629-089	FOTIVDA	Tivozanib
45629-134	FOTIVDA	Tivozanib